LncRNA KCNQ1OT1 can stabilize HK2 in osteosarcoma, colorectal cancer, and ovarian cancer, enhancing aerobic glycolysis and promoting cancer progression [88, 89]. Here, HK2 is linked to ovarian carcinoma.